{"id":22405,"date":"2026-10-01T13:00:11","date_gmt":"2026-10-01T13:00:11","guid":{"rendered":"https:\/\/www.upjs.sk\/pracoviska\/tip\/?post_type=cpt_aktuality&p=22405"},"modified":"2026-10-01T13:06:09","modified_gmt":"2026-10-01T13:06:09","slug":"eastmed-2026-tip-otvara-vyskum-projektu-apbc","status":"publish","type":"cpt_aktuality","link":"https:\/\/www.upjs.sk\/pracoviska\/tip\/actuality\/eastmed-2026-tip-otvara-vyskum-projektu-apbc\/","title":{"rendered":"EASTMED 2026: Technologick\u00fd a inova\u010dn\u00fd park UPJ\u0160 otv\u00e1ra v\u00fdskum biznisu prostredn\u00edctvom projektu APBC"},"content":{"rendered":"\n
Na konferencii EASTMED 2026 \u2013 Where Science Meets Business<\/strong>, ktor\u00e1 sa konala 23. septembra<\/strong> v\u00a0Ko\u0161iciach, diskutovali odborn\u00edci z vedy, medic\u00edny, technol\u00f3gi\u00ed a\u00a0podnikate\u013esk\u00e9ho prostredia o\u00a0tom, ako m\u00f4\u017eu firmy pri rie\u0161en\u00ed vlastn\u00fdch probl\u00e9mov vyu\u017e\u00edva\u0165 v\u00fdsledky v\u00fdskumu, odborn\u00e9 kapacity a\u00a0laborat\u00f3rnu infra\u0161trukt\u00faru univerzity. Podujatie bolo jednou z pl\u00e1novan\u00fdch aktiv\u00edt projektu Advanced Protein Biotechnology Consortium (APBC)<\/strong>, ktor\u00fd m\u00e1 pom\u00f4c\u0165 pos\u00fava\u0165 v\u00fdsledky v\u00fdskumu z laborat\u00f3ri\u00ed k ich praktick\u00e9mu vyu\u017eitiu. Zorganizovali ho Ko\u0161ice<\/strong> IT Valley<\/strong> a\u00a0Technologick\u00fd a\u00a0inova\u010dn\u00fd park UPJ\u0160 (TIP-UPJ\u0160)<\/strong>.<\/p>\n\n\n\n Konferenciu otvoril ved\u00faci Centra interdisciplin\u00e1rnych biovied TIP-UPJ\u0160<\/strong> a hlavn\u00fd rie\u0161ite\u013e projektu APBC prof. RNDr. Erik Sedl\u00e1k, DrSc.<\/strong> Zd\u00f4raznil potrebu vytv\u00e1ra\u0165 na Slovensku podmienky, v ktor\u00fdch m\u00f4\u017eu na z\u00e1klade v\u00fdsledkov v\u00fdskumu vznika\u0165 a rozv\u00edja\u0165 sa \u00faspe\u0161n\u00e9 startupy a \u010fal\u0161ie inovat\u00edvne firmy.<\/p>\n\n\n\n Ko\u0161ick\u00fd regi\u00f3n m\u00e1 kvalitn\u00fd v\u00fdskum, odborn\u00edkov aj technologick\u00fa infra\u0161trukt\u00faru. V\u00fdzvou v\u0161ak zost\u00e1va, aby firmy o t\u00fdchto mo\u017enostiach vedeli a dok\u00e1zali ich vyu\u017ei\u0165 pri rie\u0161en\u00ed svojich potrieb. Pr\u00e1ve tu m\u00f4\u017ee pom\u00f4c\u0165 TIP-UPJ\u0160<\/strong>. Firmy pritom nemusia ma\u0165 vlastn\u00e9 laborat\u00f3ri\u00e1: konkr\u00e9tny odborn\u00fd alebo technologick\u00fd probl\u00e9m m\u00f4\u017eu rie\u0161i\u0165 v spolupr\u00e1ci s univerzitn\u00fdmi odborn\u00edkmi a vyu\u017ei\u0165 dostupn\u00fa infra\u0161trukt\u00faru. \u201eVieme firm\u00e1m pon\u00faknu\u0165 zmluvn\u00fd v\u00fdskum, spolo\u010dn\u00e9 grantov\u00e9 projekty aj licencie na technol\u00f3gie, ktor\u00e9 u\u017e m\u00e1me,\u201c vysvet\u013euje RNDr. Andrej Miro\u0161\u0161ay, PhD<\/strong>., riadite\u013e TIP-UPJ\u0160.<\/p>\n\n\n\n Rozvoj takejto spolupr\u00e1ce podporuje aj projekt APBC, koordinovan\u00fd UPJ\u0160 a realizovan\u00fd od marca 2025 do augusta 2027. Toto medzin\u00e1rodn\u00e9 konzorcium zameran\u00e9 na prote\u00ednov\u00e9 biotechnol\u00f3gie zdru\u017euje v\u00fdznamn\u00e9 eur\u00f3pske v\u00fdskumn\u00e9 in\u0161tit\u00facie a dve firmy a vytv\u00e1ra podmienky na vznik nov\u00fdch technol\u00f3gi\u00ed a ich vyu\u017eitie v praxi. V r\u00e1mci projektu sa rozv\u00edjaj\u00fa r\u00f4zne formy spolupr\u00e1ce s firmami – od anal\u00fdzy vzoriek a z\u00e1kazkov\u00fdch meran\u00ed cez spolo\u010dn\u00fd v\u00fdvoj technol\u00f3gi\u00ed a\u017e po spolo\u010dn\u00e9 granty, licencie \u010di vznik spin-offov.<\/p>\n\n\n\n Na UPJ\u0160 u\u017e existuj\u00fa aj konkr\u00e9tne pr\u00edklady ciest od v\u00fdskumu k jeho vyu\u017eitiu, aktu\u00e1lne v r\u00f4znych \u0161t\u00e1di\u00e1ch transferu vedeck\u00fdch poznatkov do praxe. Patr\u00ed medzi ne spin-off SAFTRA BioMAI, pilotn\u00e9 experimenty s enz\u00fdmom chitin\u00e1zou \u010di fluorescen\u010dn\u00e1 sonda, ktor\u00e1 po \u00faspe\u0161nom nez\u00e1vislom teste na\u0161la pravideln\u00e9 vyu\u017eitie v laborat\u00f3riu. TIP-UPJ\u0160 z\u00e1rove\u0148 rozv\u00edja B2B platformu Metabolite Market, ktor\u00e1 m\u00e1 spolupr\u00e1cu univerzity a firiem \u010falej zjednodu\u0161i\u0165.<\/p>\n\n\n\n Konferencia pouk\u00e1zala aj komer\u010dn\u00fd potenci\u00e1l v\u00fdsledkov z\u00e1kladn\u00e9ho v\u00fdskumu. Pr\u00edkladom je v\u00fdskum machov a li\u0161ajn\u00edkov, ktor\u00e9mu sa venuje doc. RNDr. Michal Goga, PhD. z Pr\u00edrodovedeckej fakulty UPJ\u0160 a CIB TIP-UPJ\u0160<\/strong>. Jeho v\u00fdsledky by v bud\u00facnosti mohli n\u00e1js\u0165 vyu\u017eitie napr\u00edklad v po\u013enohospod\u00e1rstve \u010di farm\u00e1cii.<\/p>\n\n\n\n S\u00fa\u010das\u0165ou programu boli aj panelov\u00e9 diskusie From Lab to Market: \u010co rozhoduje o\u00a0\u00faspechu bio-medic\u00ednskeho produktu<\/strong> a Shaping the Future \u2013 What\u2019s Next?<\/strong>. Na z\u00e1ver podujatia sa uskuto\u010dnil organizovan\u00fd networking<\/em>, po\u010das ktor\u00e9ho sa z\u00e1stupcovia firiem a akademick\u00e9ho prostredia mohli cielene stretn\u00fa\u0165, vymeni\u0165 si sk\u00fasenosti s v\u00fdskumom, v\u00fdvojom produktov a ich uplatnen\u00edm na trhu a nadviaza\u0165 kontakty pre bud\u00facu spolupr\u00e1cu.<\/p>\n\n\n\n Cie\u013eom je vytv\u00e1ra\u0165 prostredie, v ktorom sa v\u00fdsledky kvalitn\u00e9ho v\u00fdskumu m\u00f4\u017eu systematicky pos\u00fava\u0165 z laborat\u00f3ria k technol\u00f3gi\u00e1m, firm\u00e1m a \u013eu\u010fom, ktor\u00ed ich vyu\u017eij\u00fa v praxi.<\/strong><\/p>\n\n\n\n Projekt APBC je financovan\u00fd Eur\u00f3pskou \u00faniou \u2013 NextGenerationEU prostredn\u00edctvom Pl\u00e1nu obnovy a odolnosti SR, projekt \u010d. 09I02-03-V01-00021.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Na konferencii EASTMED 2026 \u2013 Where Science Meets Business, ktor\u00e1 sa konala 23. septembra v\u00a0Ko\u0161iciach, diskutovali odborn\u00edci z vedy, medic\u00edny, technol\u00f3gi\u00ed a\u00a0podnikate\u013esk\u00e9ho prostredia o\u00a0tom, ako m\u00f4\u017eu firmy pri rie\u0161en\u00ed vlastn\u00fdch probl\u00e9mov vyu\u017e\u00edva\u0165 v\u00fdsledky v\u00fdskumu, odborn\u00e9 kapacity a\u00a0laborat\u00f3rnu infra\u0161trukt\u00faru univerzity. Podujatie bolo jednou z pl\u00e1novan\u00fdch aktiv\u00edt projektu Advanced Protein Biotechnology Consortium (APBC), ktor\u00fd m\u00e1 pom\u00f4c\u0165 pos\u00fava\u0165 … \u010c\u00edta\u0165 \u010falej<\/a><\/p>\n","protected":false},"author":116,"featured_media":22503,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"tax_aktuality":[598],"class_list":["post-22405","cpt_aktuality","type-cpt_aktuality","status-publish","has-post-thumbnail","hentry","tax_aktuality-598"],"acf":{"acf_link_na_externy_obsah":"","poradie_clanku":""},"yoast_head":"\n